Atlas Trials

Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma

Clinical trial NCT00438581 · UNKNOWN

Trial details

NCT number
NCT00438581
Sponsor
McGill University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2007-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.